Morgan Stanley’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8M Buy
303,951
+151,956
+100% +$12.2M ﹤0.01% 2863
2026
Q1
$11.5M Sell
151,995
-14,280
-9% -$1.05M ﹤0.01% 3460
2025
Q4
$11.3M Buy
166,275
+63,982
+63% +$4M ﹤0.01% 3508
2025
Q3
$5.83M Buy
102,293
+33,194
+48% +$1.97M ﹤0.01% 4021
2025
Q2
$3.83M Buy
69,099
+19,633
+40% +$921K ﹤0.01% 4276
2025
Q1
$2.16M Sell
49,466
-63,615
-56% -$2.77M ﹤0.01% 4558
2024
Q4
$4.87M Sell
113,081
-27,728
-20% -$1.25M ﹤0.01% 4022
2024
Q3
$6.29M Sell
140,809
-51,602
-27% -$2.13M ﹤0.01% 3792
2024
Q2
$7.4M Buy
192,411
+162,584
+545% +$6.2M ﹤0.01% 3564
2024
Q1
$1.03M Buy
29,827
+1,993
+7% +$64K ﹤0.01% 4940
2023
Q4
$806K Buy
27,834
+25,737
+1,227% +$587K ﹤0.01% 5046
2023
Q3
$39.7K Buy
+2,097
New +$39.8K ﹤0.01% 6262

Other funds holding DBD

Morgan Stanley's DBD Position: Q2 2026 in Review

Morgan Stanley increased its Diebold Nixdorf (DBD) stake by 100% in Q2 2026, buying an estimated $12.2M and bringing the position to 303,951 shares worth $25.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2863.

Morgan Stanley first reported a position in DBD in Q3 2023 and has held it in 12 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Morgan Stanley held 303,951 shares of Diebold Nixdorf worth $25.8M as of Q2 2026.
  • Morgan Stanley bought 151,956 Diebold Nixdorf shares in Q2 2026, an estimated $12.2M.
  • Diebold Nixdorf made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2863 holding.
  • Morgan Stanley first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 12 quarters since.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.